Clay M G
Cancer Control Agency of British Columbia, Vancouver.
Can J Surg. 1990 Feb;33(1):17-9.
Over the past 7 years at the Cancer Control Agency of British Columbia, fine-wire localization breast biopsies were performed with increasing frequency for mammographic findings suggestive of malignant disease. Because the rate of biopsy specimens negative for malignant disease was high, a policy was instituted to review all mammograms before carrying out a biopsy. As a result, the rate of positive biopsy findings increased from a mean of 29% to 33% and a further 16% of biopsy specimens were positive for premalignant disease. Of patients in whom a diagnosis of malignant disease was made, 60% had in-situ disease compared with 8.5% in the province overall. As a result of the earlier diagnosis, less radical surgery was possible. These findings support the value of mammography with fine-wire localization biopsy as a valid method for making an earlier diagnosis of breast cancer.
在过去7年里,不列颠哥伦比亚癌症控制机构对乳腺钼靶检查发现提示恶性疾病的患者越来越频繁地进行细针定位乳腺活检。由于恶性疾病活检标本阴性率较高,因此制定了一项政策,即在进行活检前对所有乳腺钼靶检查进行复查。结果,活检阳性率从平均29%提高到33%,另有16%的活检标本为癌前疾病阳性。在确诊为恶性疾病的患者中,60%患有原位疾病,而全省总体比例为8.5%。由于诊断较早,可行的手术范围较小。这些发现支持了乳腺钼靶检查结合细针定位活检作为早期诊断乳腺癌的有效方法的价值。